Patents by Inventor Andrew B. Norman

Andrew B. Norman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating cocaine-related disorders
    Patent number: 10501556
    Abstract: Methods for treating a cocaine-related disorder in an individual include administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In another embodiment, the light chain includes a human kappa light chain at least partially derived from 1B3. Other embodiments are directed toward the antibodies themselves and methods of binding the antibodies.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: December 10, 2019
    Assignees: University of Cincinnati, E. R. Squibb & Sons, L.L.C.
    Inventors: Andrew B. Norman, William J. Ball, Jr., Nils Lonberg, Denise Williams
  • Compositions and methods for treating cocaine-related disorders
    Patent number: 9957332
    Abstract: A method of treating a cocaine-related disorder in an individual is provided, the method including administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In a specific embodiment, the antibody is a monoclonal antibody comprising a murine lambda light chain variable region, a human gamma heavy chain variable region, and a human kappa or lambda light chain constant region.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: May 1, 2018
    Assignee: University of Cincinnati
    Inventors: Andrew B. Norman, William J. Ball
  • Compositions and Methods for Treating Cocaine-Related Disorders
    Publication number: 20180100025
    Abstract: A method of treating a cocaine-related disorder in an individual is provided, the method including administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In a specific embodiment, the antibody is a monoclonal antibody comprising a murine lambda light chain variable region, a human gamma heavy chain variable region, and a human kappa or lambda light chain constant region.
    Type: Application
    Filed: March 13, 2014
    Publication date: April 12, 2018
    Applicant: UNIVERSITY OF CINCINNATI
    Inventors: Andrew B. Norman, William J. Ball, JR.
  • COMPOSITIONS AND METHODS FOR TREATING COCAINE-RELATED DISORDERS
    Publication number: 20170342165
    Abstract: Methods for treating a cocaine-related disorder in an individual de administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In another embodiment, the light chain includes a human kappa light chain at least partially derived from 1B3. Other embodiments are directed toward the antibodies themselves and methods of binding the antibodies.
    Type: Application
    Filed: August 15, 2017
    Publication date: November 30, 2017
    Inventors: Andrew B. Norman, William J. Ball, Jr., Nils Lonberg, Denise Williams
  • Compositions and methods for treating cocaine-related disorders
    Patent number: 9758593
    Abstract: Methods for treating a cocaine-related disorder in an individual include administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In another embodiment, the light chain includes a human kappa light chain at least partially derived from 1B3. Other embodiments are directed toward the antibodies themselves and methods of binding the antibodies.
    Type: Grant
    Filed: April 20, 2007
    Date of Patent: September 12, 2017
    Assignees: University of Cincinnati, E. R. Squibb & Sons, L.L.C.
    Inventors: Andrew B. Norman, William J. Ball, Jr., Nils Lonberg, Denise Williams
  • Compositions and Methods for Treating Cocaine-Related Disorders
    Publication number: 20140220009
    Abstract: A method of treating a cocaine-related disorder in an individual is provided, the method including administering to the individual a therapeutic amount of an antibody comprising a human immunoglobulin gamma heavy chain and a murine lambda light chain. In a specific embodiment, the antibody is a monoclonal antibody comprising a murine lambda light chain variable region, a human gamma heavy chain variable region, and a human kappa or lambda light chain constant region.
    Type: Application
    Filed: March 13, 2014
    Publication date: August 7, 2014
    Applicant: UNIVERSITY OF CINCINNATI
    Inventors: Andrew B. Norman, William J. Ball, JR.